Table 1.

National infectious disease screening recommendations for asylum seekers

Infectious disease	Target population	Screening indication	Screening test
Pulmonary tuberculosis	All	Tuberculosis (TB) incidence 50/100000 or above in the country of origin, or originating from conflict areas, or having lived in camp settings, or close contacts to TB patients, or symptoms of TB	Chest X-ray from twoa projections (CXR)
Latent extra-pulmonary tuberculosis	BCG-unvaccinated children under 7 years of age	Tuberculosis (TB) incidence 50/100000 or above in the country of origin, or originating from conflict areas, or having lived in camp settings, or close contacts to TB, or symptoms of TB	Interferon Gamma Realease Assay (IGRA)
Hepatitis B	All	HBsAg prevalence above 2% in the country of origin or transit	Serum Hepatitis B surface antigen (HBsAg)
HIV	All	HIV prevalence above 1% in the country of origin or transit, or specific risk behavior such as injecting drug use, sex between men, incarceration, commercial sex work, or an individuals own request	Serum Human Immunodeficiency Virus antigen and antibodies (HIVAgAb)
Syphilis	All	If HBsAG or HIVAgAb screening is performed	Serum Treponema pallidum antibodies (anti-Trpa)
Intestinal parasites	Children under 16 years of age	Country of origin or transit in South-East Asia, India or Sub-Saharan Africa	Direct microscopy of fecal parasites

^aWith the exception for asymptomatic pregnant women, CXR is recommended to be perfomed after 36 gestational weeks and from anterio-posterior projection only